Lineage Cell Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update

Go back to Lineage Cell Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
(NYSE: LCTX) Delayed: 1.26 +0.05 (4.13%)
Previous Close $1.21    52 Week High
Open $1.24    52 Week Low
Day High $1.28    P/E N/A 
Day Low $1.22    EPS
Volume 1,514,822       

(NYSE: LCTX) Delayed: 1.26 +0.05 (4.13%)
Previous Close $1.21    52 Week High
Open $1.24    52 Week Low
Day High $1.28    P/E N/A 
Day Low $1.22    EPS
Volume 1,514,822